THE NATURE OF LIVER INJURY IN COVID-19, AS WELL AS THE CLINICAL COURSE'S SPECIFICITY
Keywords:
Hepatitis, liver fibrosis, aspartataminotransferase, alaninaminotransferase, gammagglutamiltranspeptidaseAbstract
For many years, chronic liver diseases have been one of the main and urgent problems of the fields of Gastroenterology and Hepatology. In particular, statistical indicators show that in the last 20 years, the incidence of liver diseases in the population has increased significantly. In a single case, statistics obtained on the scale of the CIS countries show that as a result of observations conducted in the population for 12 months, from 500 to 1,000,000 people were registered liver diseases caused by damage to the liver by various etiological factors. Unfortunately, to date, about 2 billion residents on Earth suffer from liver diseases. From year to year, the reason for the increased damage to liver cells is the increased diversity of etiological factors. In particular, with the damage of liver cells to medicamentosis, viral, toxic, alcohol and autoimmune, 2-3 million inhabitants are being registered every year. For this reason, we can cite the fact that most drug preparations are metabolized in the liver, that carbohydrates, proteins, fats are metabolized in the liver, and that the liver plays an important role in external and internal disintoxication.
References
Yang X., Yu Y., Xu J., et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study // Lancet Respir Med. – 2020. – No.8. –
Р. 475–481. – doi: 10.1016/s2213-2600(20)30079-5.
В.И. Петров1,4, А.В. Пономарева1,5, И.В. Ивахненко2, О.В. Разваляева3, Б.А. Мешрки6, В.И. Стаценко1. ЭТИОПАТОГЕНЕТИЧЕСКИЕ АСПЕКТЫ ПОВРЕЖДЕНИЯ ПЕЧЕНИ У ПАЦИЕНТОВ С COVID-19 // Вестник ВолгГМУ –Выпуск 4 ( 76 ). 2020 . С. 11- УДК 616-06
Nurbaev, F. E. (2022). Raupov AO Sharipova NK Dzhumaev H. Liver lesions in GOVID-19: etiology, clinic, prognosis, treatment and prevention. Bukhara scientific-abstract, spiritual and educational journal, 11, 49.
Boettler T., Newsome P.N., Mondelli M.U. et al. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper // JHEP Reports. 2020.
Waseem N., Chen P.H. Hypoxic hepatitis: a review and clinical update // J Clin TranslHepatol. – 2021. – No. 4. – Р. 263–268. – doi: 10.14218/jcth.2021.00022.
Mehta P., McAuley D.F., Brown M., et al. HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression // Lancet. – 2020. – No. 395. – Р. 1033–1034. – doi: 10.1016/s0140-6736(20)30628-0.
Гриневич В. Б., Кравчук Ю. А., Педь В. И. и др. / Grinevich V. B., Kravchuk Yu. A., Ped V. I., et al. Ведение пациентов с заболеваниями органов пищеварения в период пандемии COVID-19. Клинические рекомендации Научного общества гастроэнтерологов России / Vedenie pacientov s zabolevaniyami organov pishhevareniya v period pandemii COVID-19. Klinicheskie rekomendacii Nauchnogo obshhestva gastroe`nterologov Rossii [Management of patients with digestive diseases during the COVID-19 pandemic: Clinical Practice Guidelines by
the Gastroenterological Scientifi c Society of Russia] // Экспериментальная и клиническая гастроэнтерология / E`ksperimental`naya i klinicheskaya gastroe`nterologiya [Experimental and Clinical Gastroenterology]. – 2020. – № 179 (7). – С. 4–51. – doi: 10.31146/1682-8658-ecg-179- 7-4-51. (In Russ.; abstr. in Engl.).
Драпкина О.М., Маев И.В., Бакулин И.Г. и др. / Drapkina O.M., Maev I.V., Bakulin I.G. et al. Временные методические рекомендации: «Болезни органов пищеварения в условиях пандемии новой коронавирусной инфекции (COVID-19)» / Vremenny`e metodicheskie rekomendacii: «Bolezni organov pishhevareniya v usloviyax pandemii novoj koronavirusnoj infekcii (COVID-19)» [Interim guidelines: «Diseases of the digestive system in the context of the novel coronavirus infection (COVID-19) pandemic»] // Профилактическая медицина / Profilakticheskaya medicina [Тhe Russian Journal оf Preventive Medicine]. – 2020. – Т. 23, № 3. – С. 2120–2152. – doi:10.17116/profmed202023032120. (In Russ.; abstr. in Engl.).
Lei F., Liu Y.M., Zhou F., et al. Longitudinal association between markers of liver injury and mortality in COVID-19 in China // Hepatology. – 2020. – No. 72 (2). – Р. 389–398. – doi: 10.1002/hep.31301.
Xie H., Zhao J., Lian N., et al. Clinical characteristics of non-ICU hospitalized patients withcoronavirus disease 2019 and liver injury: A retrospective study // Liver Int. – 2020. – No. 40. – Р. 1321–1326. – doi: 10.1111/liv.14449.
